Invention Grant
- Patent Title: Chemical inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence
-
Application No.: US16955385Application Date: 2018-12-21
-
Publication No.: US11617740B2Publication Date: 2023-04-04
- Inventor: Robert Abramovitch , Edmund Ellsworth
- Applicant: Board of Trustees of Michigan State University
- Applicant Address: US MI East Lansing
- Assignee: Board of Trustees of Michigan State University
- Current Assignee: Board of Trustees of Michigan State University
- Current Assignee Address: US MI East Lansing
- Agency: Foley Hoag LLP
- International Application: PCT/US2018/067025 WO 20181221
- International Announcement: WO2019/126613 WO 20190627
- Main IPC: A61K31/422
- IPC: A61K31/422 ; A61P31/04 ; A61K31/357 ; A61K31/42 ; C07D261/14 ; C07D413/12
Abstract:
Provides herein are novel compounds, compositions, and methods useful for inhibiting bacteria, such as Mycobacterium tuberculosis. These compositions and methods find many uses in medicine and research, e.g., treating subjects afflicted with active or latent bacterial infections.
Public/Granted literature
- US20210000799A1 CHEMICAL INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS DOSRST SIGNALING AND PERSISTENCE Public/Granted day:2021-01-07
Information query
IPC分类:
